Differentially methylated CpG sites in response to E2, P4, E2+P4 (vs. vehicle) in endometriosis stage IV eSF, based on loss and gain of methylation.

Sahar Houshdaran (193196); Ashwini B. Oke (8985506); Jennifer C. Fung (8985509); Kim Chi Vo (8985512); Camran Nezhat (8985515); Linda C. Giudice (3752785)

doi:10.1371/journal.pgen.1008601.s010

Differentially methylated CpG sites in response to E2, P4, E2+P4 (vs. vehicle) in endometriosis stage IV eSF, based on loss and gain of methylation.

Sahar Houshdaran (193196), Ashwini B. Oke (8985506), Jennifer C. Fung (8985509), Kim Chi Vo (8985512), Camran Nezhat (8985515), Linda C. Giudice (3752785)

2020 · doi:10.1371/journal.pgen.1008601.s010 · W6904106336

dataset OA: green CC0

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-16 ⓘ

This study identified differentially methylated CpG sites in endometriosis stage IV endometrial stromal fibroblasts exposed to estradiol, progesterone, or both, compared to vehicle treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex: last seen: 2026-05-11T08:48:50.894309+00:00

License: CC0 · commercial use OK